Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ao Huang

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Molecular Therapy. Nucleic Acids|January 16, 2026
Ribofuranose-based GalNAc-conjugated siRNA enhances the liver-targeted delivery and elicits robust RNAi-mediated gene silencingZe-Ao Huang, Zhen-Min Li, Jie Wang, et al.
Journal of the American Chemical Society|June 26, 2026
Regulating Interfacial Water Distribution and Ion Transport by Rigid-Flexible Dual-Piperidinium Ionomer toward Enhanced CO<sub>2</sub> ElectrolysisJia-Ao Huang, Hui Fan, Wei Yuan, et al.
Foods (Basel, Switzerland)|December 17, 2024
Correlations Between the Bacterial and Fungal Flora and Amino Acid Composition of the Zhuangzu Acid Congee Produced Around the Zuojiang River Basin, GuangxiAo Huang, Qin-Ren Zhang, De-Qiang Xiao, et al.
Portal Hypertension & Cirrhosis|July 15, 2026
Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management ImplicationsJiayan Yan, Jiayi Wang, Jian Fan, et al.
Chemical Communications (Cambridge, England)|January 27, 2026
A crystalline-amorphous interface enriched CuS-SnS composite catalyst boosts electrochemical CO<sub>2</sub> reduction over a wide pH windowShanshan Wang, Baoxin Ni, Wei-Yi Zhang, et al.
Frontiers in Immunology|March 13, 2023
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapyDe-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Annals of Translational Medicine|November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteriaDe-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
The Oncologist|March 27, 2019
Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching AnalysisZi-Jun Gong, Jian-Wen Cheng, Pin-Ting Gao, et al.
Frontiers in Oncology|March 13, 2023
Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapyDe-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Clinical and Translational Medicine|February 26, 2021
Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergisticallyXin Zhang, Bo Hu, Yun-Fan Sun, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Molecular Therapy. Nucleic Acids|January 16, 2026
Ribofuranose-based GalNAc-conjugated siRNA enhances the liver-targeted delivery and elicits robust RNAi-mediated gene silencingZe-Ao Huang, Zhen-Min Li, Jie Wang, et al.
Journal of the American Chemical Society|June 26, 2026
Regulating Interfacial Water Distribution and Ion Transport by Rigid-Flexible Dual-Piperidinium Ionomer toward Enhanced CO<sub>2</sub> ElectrolysisJia-Ao Huang, Hui Fan, Wei Yuan, et al.
Foods (Basel, Switzerland)|December 17, 2024
Correlations Between the Bacterial and Fungal Flora and Amino Acid Composition of the Zhuangzu Acid Congee Produced Around the Zuojiang River Basin, GuangxiAo Huang, Qin-Ren Zhang, De-Qiang Xiao, et al.
Portal Hypertension & Cirrhosis|July 15, 2026
Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management ImplicationsJiayan Yan, Jiayi Wang, Jian Fan, et al.
Chemical Communications (Cambridge, England)|January 27, 2026
A crystalline-amorphous interface enriched CuS-SnS composite catalyst boosts electrochemical CO<sub>2</sub> reduction over a wide pH windowShanshan Wang, Baoxin Ni, Wei-Yi Zhang, et al.
Frontiers in Immunology|March 13, 2023
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapyDe-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Annals of Translational Medicine|November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteriaDe-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
The Oncologist|March 27, 2019
Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching AnalysisZi-Jun Gong, Jian-Wen Cheng, Pin-Ting Gao, et al.
Frontiers in Oncology|March 13, 2023
Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapyDe-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Clinical and Translational Medicine|February 26, 2021
Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergisticallyXin Zhang, Bo Hu, Yun-Fan Sun, et al.
Pageof 16